Headache medication and the COVID-19 pandemic by Headache Scientific Panel
Category
Breaking news
-
-
Breaking newsEAN NewsResearchCOVID-19
COVID‐19 and Headache: A Primer for Trainees
November 20, 2020COVID‐19 and Headache: A Primer for Trainees by Headache Scientific Panel -
Breaking newsEAN NewsResearchCOVID-19
Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia
November 20, 2020Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia -
Breaking newsEAN NewsCOVID-19Research
COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management
November 4, 2020COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management -
Breaking newsEAN NewsResearchCOVID-19
The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries
November 4, 2020The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries -
Breaking newsEAN NewsResearchCOVID-19
Ischemic Stroke Occurs Less Frequently in Patients With COVID-19 A Multicenter Cross-Sectional Study
November 4, 2020Ischemic Stroke Occurs Less Frequently in Patients With COVID-19 A Multicenter Cross-Sectional Study -
Breaking newsEAN NewsCOVID-19Research
EXPRESS: Stroke in COVID-19: a systematic review and meta-analysis
November 4, 2020EXPRESS: Stroke in COVID-19: a systematic review and meta-analysis -
Breaking newsEAN NewsResearchCOVID-19
New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review
November 4, 2020New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review -
Breaking newsEAN NewsResearchCOVID-19
Severe COVID-19-related encephalitis can respond to immunotherapy.
November 4, 2020Severe COVID-19-related encephalitis can respond to immunotherapy. -
Breaking newsEAN NewsResearchCOVID-19
The cognitive consequences of the COVID-19 epidemic: collateral damage?
November 4, 2020The cognitive consequences of the COVID-19 epidemic: collateral damage? -
Breaking newsEAN NewsResearchCOVID-19
Death Rate Due to COVID-19 in Alzheimer’s Disease and Frontotemporal Dementia
November 4, 2020Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia -
Breaking newsEAN NewsCOVID-19
Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series
November 4, 2020Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series -
Breaking newsEAN NewsResearchCOVID-19
Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown
November 4, 2020Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown -
Breaking newsEAN NewsResearchCOVID-19
Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses
November 4, 2020Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses -
Breaking newsEAN NewsCOVID-19Research
CSF biomarkers in patients with COVID-19 and neurological symptoms A case series
November 4, 2020CSF biomarkers in patients with COVID-19 and neurological symptoms A case series